A simplified in vitro ligation approach to clone an E1B55k-deleted double-targeted conditionally-replicative adenovirus

Virology Journal

Volumn 6, Issue , 2009, Pages

  Haviv, Yosef S ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CONDITIONALLY REPLICATING ADENOVIRUS; E1A PROTEIN; GLYCOPROTEIN E1; HEAT SHOCK PROTEIN 70; E1B PROTEIN;

ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE STRUCTURE; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; VIRUS GENOME; VIRUS REPLICATION; ADENOVIRUS; CELL LINE; EVALUATION; GENETIC PROCEDURES; GENETICS; METABOLISM; PHYSIOLOGY;

ADENOVIRIDAE;

ADENOVIRIDAE; ADENOVIRUS E1B PROTEINS; CELL LINE; CLONING, MOLECULAR; GENETIC TECHNIQUES; HSP70 HEAT-SHOCK PROTEINS; HUMANS; SEQUENCE DELETION; VIRUS REPLICATION;

EID: 61449208225     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-6-18     Document Type: Article

References (36)

1. Generation of adenovirus by transfection of plasmids. KL Berkner PA Sharp, Nucleic Acid Res 1983 11 17 6003 20 6310523 10.1093/nar/11.17.6003
2. Covalently closed circles of adenovirus 5 DNA. M Ruben S Bacchetti FL Graham, Nature 1983 301 5896 172 4 10.1038/301172a0 6823294
3. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. WJ McGrory DS Bautista FL Graham, Virology 1988 163 2 614 7 10.1016/0042-6822(88)90302-9 2965450
4. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. AJ Bett W Haddara L Prevec FL Graham, PNAS 1994 91 19 8802 6 8090727 10.1073/pnas.91.19.8802
5. An enhanced system for construction of adenoviral vectors by the two-plasmid rescue method. P Ng RJ Parks DT Cummings CM Evelegh FL Graham, Hum Gene Ther 2000 11 5 693 9 10.1089/10430340050015590 10757349
6. A simplified system for generating recombinant adenoviruses. TC He S Zhou LT da Costa J Yu KW Kinzler B Vogelstein, PNAS 1998 95 5 2509 14 9482916 10.1073/pnas.95.5.2509
7. New tools for the generation of E1- and/or E3-substituted adenoviral vectors. X Danthinne E Werth, Gene Ther 2000 7 1 80 7 10.1038/sj.gt.3301047 10680020
8. Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method. H Mizuguchi MA Kay, Hum Gene Ther 1998 9 17 2577 83 10.1089/hum.1998.9.17-2577 9853524
9. A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors. H Mizuguchi MA Kay, Hum Gene Ther 1999 10 12 2013 7 10.1089/10430349950017374 10466635
10. Novel cloning method for recombinant adenovirus construction in Escherichia coli. DW Souza D Armentano, Biotechniques 1999 26 3 502 8 10090992
11. Cloning of a DNA fragment from the left-hand terminus of the adenovirus type 2 genome and its use in site-directed mutagenesis. ND Stow, J Virol 1981 37 1 171 80 6260971
12. Engineering regulatory elements for conditionally-replicative adenoviruses. YS Haviv DT Curiel, Curr Gene Ther 2003 3 4 357 85 10.2174/1566523034578311 12871022
13. A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy. SO Freytag KR Rogulski DL Paielli JD Gilbert JH Kim, Hum Gene Ther 1998 9 9 1323 33 10.1089/hum.1998.9.9-1323 9650617
14. A midkine promoter-based conditionally replicative adenovirus for treatment of pediatric solid tumors and bone marrow tumor purging. Y Adachi PN Reynolds M Yamamoto M Wang K Takayama S Matsubara T Muramatsu DT Curiel, Cancer Res 2001 61 21 7882 8 11691808
15. Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses for pan-carcinoma application. K Takayama PN Reynolds Y Adachi L Kaliberova J Uchino Y Nakanishi DT Curiel, Cancer Gene Ther 2007 14 1 105 16 17024232 10.1038/sj.cgt.7700991
16. A conditionally replicating adenovirus targeted to tumor cells through activated RAS/P-MAPK-selective mRNA stabilization. A Ahmed J Thompson L Emiliusen S Murphy RD Beauchamp K Suzuki R Alemany K Harrington RG Vile, Nat Biotechnol 2003 21 7 771 7 10.1038/nbt835 12794639
17. Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cells. GJ Bauerschmitz K Guse A Kanerva A Menzel I Herrmann RA Desmond M Yamamoto DM Nettelbeck T Hakkarainen P Dall DT Curiel A Hemminki, Mol Ther 2006 14 2 164 74 10.1016/j.ymthe.2006.01.010 16580264
18. Novel oncolytic adenoviruses targeted to melanoma: specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer/promoter. DM Nettelbeck AA Rivera C Balagué R Alemany DT Curiel, Cancer Res 2002 62 16 4663 70 12183423
19. Late expression of p53 from a replicating adenovirus improves tumor cell killing and is more tumor cell specific than expression of the adenoviral death protein. H Sauthoff T Pipiya S Heitner S Chen RG Norman WN Rom JG Hay, Hum Gene Ther 2002 13 15 1859 71 10.1089/104303402760372954 12396618
20. Insulated hsp70B' promoter: stringent heat-inducible activity in replication-deficient, but not replication-competent adenoviruses. S Rohmer A Mainka I Knippertz A Hesse DM Nettelbeck, J Gene Med 2008 10 4 340 54 10.1002/jgm.1157 18265421
21. A broadly applicable, personalized heat shock protein-mediated oncolytic tumor vaccine. XF Huang W Ren L Rollins P Pittman M Shah L Shen Q Gu R Strube F Hu SY Chen, Cancer Res 2003 63 21 7321 9 14612530
22. Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli. D Hoffmann O Wildner, BMC Biotechnol 2006 6 36 16887042 10.1186/1472-6750-6-36
23. A novel, conditionally replicative adenovirus for the treatment of breast cancer that allows controlled replication of E1a-deleted adenoviral vectors. R Hernandez-Alcoceba M Pihalja MS Wicha MF Clarke, Hum Gene Ther 2000 11 14 2009 24 10.1089/10430340050143435 11020800
24. Specific oncolytic effect of a new hypoxia-inducible factor-dependent replicative adenovirus on von Hippel-Lindau-defective renal cell carcinomas. Y Cuevas R Hernndez-Alcoceba J Aragones S Naranjo-Surez MC Castellanos MA Esteban S Martín-Puig MO Landazuri L del Peso, Cancer Research 2003 63 6877 6884 14583486
25. Gene Therapy for Prostate Cancer by Controlling Adenovirus E1a and E4 Gene Expression with PSES Enhancer. X Li YP Zhang HS Kim KH Bae KM Stantz SJ Lee C Jung JA Jiménez TA Gardner MH Jeng C Kao, Cancer Research 2005 65 1941 1951 10.1158/0008-5472.CAN-04-3666 15753394
26. Transcriptional targeting modalities in breast cancer gene therapy using adenovirus vectors controlled-lactalbumin promoter. X Li J Zhang H Gao E Vieth KH Bae YP Zhang SJ Lee S Raikwar TA Gardner GD Hutchins D VanderPutten C Kao MH Jeng, Mol Cancer Ther 2005 4 1850 1859 10.1158/1535-7163.MCT-05-0167 16373700
27. Targeted virus replication plus immunotherapy eradicates primary and distant pancreatic tumors in nude mice. D Sarkar ZZ Su N Vozhilla ES Park A Randolph K Valerie PB Fisher, Cancer Res 2005 65 19 9056 63 10.1158/0008-5472. CAN-05-1261 16204080
28. Eradication of Therapy-Resistant Human Prostate Tumors Using a Cancer Terminator Virus. D Sarkar IV Lebedeva ZZ Su ES Park L Chatman N Vozhilla P Dent DT Curiel PB Fisher, Cancer Research 2007 67 5434 5442 10.1158/0008-5472.CAN- 07-0195 17545625
29. A rapid and easy method for production and selection of recombinant adenovirus genomes. L Renaut C Bernard JC D'Halluin, J Virol Methods 2002 100 1-2 121 31 10.1016/S0166-0934(01)00407-4 11742659
30. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. DR Ciocca SK Calderwood, Cell Stress Chaperones 2005 10 2 86 103 16038406 10.1379/CSC-99r.1
31. Cooperative binding of heat shock transcription factor to the Hsp70 promoter in vivo and in vitro. J Amin M Fernandez J Ananthan JT Lis R Voellmy, J Biol Chem 1994 269 7 4804 11 8106450
32. Spatial and temporal control of expression of therapeutic genes using heat shock protein promoters. C Rome F Couillaud CT Moonen, Methods 2005 35 2 188 98 10.1016/j.ymeth.2004.08.011 15649846
33. Replicating adenoviral vector-mediated transfer of a heat-inducible double suicide gene for gene therapy. YJ Lee SS Galoforo P Battle H Lee PM Corry JM Jessup, Cancer Gene Ther 2001 8 6 397 404 10.1038/sj.cgt.7700310 11498759
34. Heat shock and heat shock protein 70i enhance the oncolytic effect of replicative adenovirus. YS Haviv JL Blackwell H Li M Wang X Lei DT Curiel, Cancer Res 2001 61 23 8361 5 11731408
35. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. JR Bischoff DH Kirn A Williams C Heise S Horn M Muna L Ng JA Nye A Sampson-Johannes A Fattaey F McCormick, Science 1996 274 5286 373 6 10.1126/science.274.5286.373 8832876
36. Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity. CC O'Shea L Johnson B Bagus S Choi C Nicholas A Shen L Boyle K Pandey C Soria J Kunich Y Shen G Habets D Ginzinger F McCormick, Cancer Cell 2005 6 6 611 623 10.1016/j.ccr.2004.11.012